Cargando…
Angiotensin II, III, and IV may be important in the progression of COVID-19
Autores principales: | Cure, Erkan, Ilcol, Tevfik Bulent, Cumhur Cure, Medine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658520/ https://www.ncbi.nlm.nih.gov/pubmed/33169633 http://dx.doi.org/10.1177/1470320320972019 |
Ejemplares similares
-
Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension
por: Cure, Erkan, et al.
Publicado: (2020) -
The controversy of using angiotensin-converting enzyme inhibitors and
angiotensin receptor blockers in COVID-19 patients
por: Harky, Amer, et al.
Publicado: (2021) -
The Renin-Angiotensin system and SARS-CoV-2 infection: A role for the ACE2 receptor?
por: Sever, Peter, et al.
Publicado: (2020) -
Could angiotensin-converting enzyme 1 I/D polymorphism be a
modificator of COVID-19 response in different populations, diseases, and/or
conditions?
por: Dević Pavlić, Sanja, et al.
Publicado: (2020) -
In vitro analysis of the renin–angiotensin system and inflammatory
gene transcripts in human bronchial epithelial cells after infection with severe
acute respiratory syndrome coronavirus
por: Turk, Can, et al.
Publicado: (2020)